Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Michael Jung has worked on the following 12 EPO patent applications which have been published in the last five years:

EP12728037

MANAGEMENT METHOD AND SYSTEM FOR IMPLEMENTATION, EXECUTION, DATA COLLECTION, AND DATA ANALYSIS OF A STRUCTURED COLLECTION PROCEDURE WHICH RUNS ON A COLLECTION DEVICE

IPC classification:
A61B 5/145, G06Q 50/22
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Multiple attorneys, Roche Diagnostics GmbH
Status:
EXAMINATION IN PROGRESS
EP12728038

MANAGEMENT METHOD AND SYSTEM FOR IMPLEMENTATION, EXECUTION, DATA COLLECTION, AND DATA ANALYSIS OF A STRUCTURED COLLECTION PROCEDURE WHICH RUNS ON A COLLECTION DEVICE

IPC classification:
A61B 5/145, G06Q 50/22
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Multiple attorneys, Roche Diagnostics GmbH
Status:
GRANT OF PATENT INTENDED
EP12740895

DNA POLYMERASES WITH IMPROVED ACTIVITY

IPC classification:
C12N 9/12, C12N 15/09, C12P 19/34
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12741249

ENCODED BIOSENSORS AND METHODS OF MANUFACTURE AND USE THEREOF

IPC classification:
G01N 27/327, G01N 33/487
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Andrew Peter Clark, J A Kemp
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
EXAMINATION IN PROGRESS
EP12745781

IN VITRO TUMOR METASTASIS MODEL

IPC classification:
G01N 33/50
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12198881

Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer

IPC classification:
G01N 21/17, G01N 21/25, G01N 21/27, G01N 33/53
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
APPLICATION WITHDRAWN
EP12743901

PREDICTING RESPONSE TO ANTI-CD20 THERAPY IN DLBCL PATIENTS

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Multiple attorneys, Roche Diagnostics GmbH
Status:
PATENT GRANTED
EP12753666

L-FABP BASED DIAGNOSIS OF KIDNEY INJURY AFTER AN ACUTE EVENT OR AFTER A SURGICAL INTERVENTION

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Multiple attorneys, Roche Diagnostics GmbH
Status:
GRANT OF PATENT INTENDED
EP13189020

Method for preventing high molecular weight products during amplification

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
PATENT GRANTED
EP13180560

Method for the detection of the prozone effect of photometric assays

IPC classification:
G01N 33/53
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14157165

Soluable and immunoreactive variants of HTLV capsid antigen p24

IPC classification:
C07K 14/005, G01N 33/569
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
APPLICATION REFUSED
EP13164176

A method of detecting nucleic acid targets using a statistical classifier

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Michael Jung, Roche Diagnostics GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature